103 related articles for article (PubMed ID: 23155224)
1. Pre- and postoperative treatment modalities for esophageal squamous cell carcinoma.
Thallinger CM; Kiesewetter B; Raderer M; Hejna M
Anticancer Res; 2012 Nov; 32(11):4609-27. PubMed ID: 23155224
[TBL] [Abstract][Full Text] [Related]
2. Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus.
Adham M; Baulieux J; Mornex F; de La Roche de Bransat E; Ducerf C; Souquet JC; Gerard JP
Cancer; 2000 Sep; 89(5):946-54. PubMed ID: 10964323
[TBL] [Abstract][Full Text] [Related]
3. [Value of radiotherapy and chemotherapy in treatment of operable cancers of the esophagus].
Msika S; Hay JM
J Chir (Paris); 2002 Feb; 139(1):17-24. PubMed ID: 12071024
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and network meta-analysis of neoadjuvant therapy combined with surgery for patients with resectable esophageal squamous cell carcinoma.
Huang Y; Wang H; Luo G; Zhang Y; Wang L; Li K
Int J Surg; 2017 Feb; 38():41-47. PubMed ID: 28027995
[TBL] [Abstract][Full Text] [Related]
5. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.
Chao YK; Chan SC; Chang HK; Liu YH; Wu YC; Hsieh MJ; Tseng CK; Liu HP
Eur J Surg Oncol; 2009 Mar; 35(3):289-94. PubMed ID: 18396384
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer.
Kranzfelder M; Schuster T; Geinitz H; Friess H; Büchler P
Br J Surg; 2011 Jun; 98(6):768-83. PubMed ID: 21462364
[TBL] [Abstract][Full Text] [Related]
7. Optimal treatment for localized esophageal cancer still uncertain.
Lord RV
Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
[TBL] [Abstract][Full Text] [Related]
8. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.
Tachimori Y; Kanamori N; Uemura N; Hokamura N; Igaki H; Kato H
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):49-54. PubMed ID: 19154902
[TBL] [Abstract][Full Text] [Related]
9. [Place of neoadjuvant treatments in oesophageal cancers care].
Créhange G; Lorchel F; Bosset JF
Bull Cancer; 2006 Nov; 93(11):1107-13. PubMed ID: 17145580
[TBL] [Abstract][Full Text] [Related]
10. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.
Brücher BL; Becker K; Lordick F; Fink U; Sarbia M; Stein H; Busch R; Zimmermann F; Molls M; Höfler H; Siewert JR
Cancer; 2006 May; 106(10):2119-27. PubMed ID: 16607651
[TBL] [Abstract][Full Text] [Related]
11. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
[TBL] [Abstract][Full Text] [Related]
12. [Neoadjuvant chemotherapy followed by surgery as standard treatment for stage II + III thoracic esophageal squamous cell carcinoma in Japan].
Sato M; Ando N
Nihon Geka Gakkai Zasshi; 2011 Mar; 112(2):104-10. PubMed ID: 21488343
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategy for superficial pharyngeal squamous cell carcinoma synchronously combined with esophageal cancer.
Kaneko K; Yano T; Minashi K; Kojima T; Ito M; Satake H; Yajima Y; Yoda Y; Ikematsu H; Oono Y; Hayashi R; Onozawa M; Ohtsu A
Oncology; 2013; 84(1):57-64. PubMed ID: 23128894
[TBL] [Abstract][Full Text] [Related]
14. Patients with locally advanced esophageal carcinoma nonresponder to radiochemotherapy: who will benefit from surgery?
Piessen G; Briez N; Triboulet JP; Mariette C
Ann Surg Oncol; 2007 Jul; 14(7):2036-44. PubMed ID: 17453293
[TBL] [Abstract][Full Text] [Related]
15. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.
Gebski V; Burmeister B; Smithers BM; Foo K; Zalcberg J; Simes J;
Lancet Oncol; 2007 Mar; 8(3):226-34. PubMed ID: 17329193
[TBL] [Abstract][Full Text] [Related]
16. [Changes and complication rate in surgery for thoracic esophageal carcinoma].
Meyer T; Merkel S; Göhl J; Stumpf P; Hohenberger W
Zentralbl Chir; 2003 Aug; 128(8):631-9. PubMed ID: 12931257
[TBL] [Abstract][Full Text] [Related]
17. Surgery within multimodal therapy concepts for esophageal squamous cell carcinoma (ESCC): the MRI approach and review of the literature.
Kranzfelder M; Büchler P; Friess H
Adv Med Sci; 2009; 54(2):158-69. PubMed ID: 20022858
[TBL] [Abstract][Full Text] [Related]
18. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
Ancona E; Ruol A; Santi S; Merigliano S; Sileni VC; Koussis H; Zaninotto G; Bonavina L; Peracchia A
Cancer; 2001 Jun; 91(11):2165-74. PubMed ID: 11391598
[TBL] [Abstract][Full Text] [Related]
19. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer.
Nakamura T; Hayashi K; Ota M; Eguchi R; Ide H; Takasaki K; Mitsuhashi N
Am J Surg; 2004 Sep; 188(3):261-6. PubMed ID: 15450831
[TBL] [Abstract][Full Text] [Related]
20. Aggressive concurrent chemoradiotherapy and surgical resection for proximal esophageal squamous cell carcinoma.
Adelstein DJ; Rice TW; Tefft M; Koka A; Van Kirk MA; Kirby TJ; Taylor ME
Cancer; 1994 Sep; 74(6):1680-5. PubMed ID: 8082068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]